Stock Detail
CAMBREX CORPORATION
Biotechnology
CBM @ Yahoo Finance | CBM Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $6.30 | $6.49 | $-0.07 | -1.10% | 0.00 | $6.37 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $6.30 | $6.22 | 88,327 | 185.77M | 123,257.5 | 11.95 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 6.61 | 6.46 | 6.34 | 6.19 | 6.07 |
Stock Profile
Cambrex Corporation and its subsidiaries provide products and services to accelerate drug discovery, development, and manufacturing processes for human therapeutics worldwide. It operates through three segments: Bioproducts, Biopharma, and Human Health. The Bioproducts segment offers research products and therapeutic application products; The Biopharma segment provides contract biopharmaceutical process development and manufacturing services; and The Human Health segment produces active pharmaceutical ingredients and pharmaceutical intermediates for use in the production of prescription and over-the-counter drug products, as well as other custom chemicals derived from organic chemistry. Cambrex Corporation sells its products through its direct sales force, independent distributors, and its e-commerce Web site to pharmaceutical and biopharmaceutical companies, generic drug companies, biotechnology companies, and research organizations. The company was founded in 1981 and is based in East Rutherford, New Jersey.